Gestational Diabetes Mellitus Clinical Trials
2 recruiting trials for Gestational Diabetes Mellitus. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Gestational Diabetes Mellitus clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Fudan University (1), Guangzhou Women and Children's Medical Center (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Time-limited eating (behavioral, 1 trial).
Track Gestational Diabetes Mellitus trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Study of the Intervention of Time-restricted Eating in High-risk Populations of GDM
This is a randomized controlled trial, aiming to investigate whether a time-restricted eating (TRE) can reduce the incidence of gestational diabetes mellitus (GDM) in high-risk...
GDM and Its Consequences in Mothers and Offsprings
Gestational diabetes mellitus (GDM) is one of the most common disorders which occured during pregnancy. GDM is not only associated with short-term maternal and fetal adverse...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Gestational Diabetes Mellitus, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Gestational Diabetes Mellitus, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Gestational Diabetes Mellitus, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.